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Mawasiliano 141Reperfusion therapy is the primary treatment for ST-elevation
myocardial infarction (STEMI). It is an attempt to minimize
the myocardial damage and improve clinical outcomes by
restoring blood ﬂow. Resolution of ST-elevation on electrocar-
diogram is considered a positive variable assessing the efﬁcacy
of coronary ﬂow restoration. In the last two decades several
studies have demonstrated a new phenomenon named ‘‘reper-
fusion peak’’ (RP).1,2 It is a transient ST-elevation in patients
undergoing either primary percutaneous coronary intervention
or thrombolytic therapy followed by complete ST-resolution.
It has been observed in 68–75% of patients treated with
thrombolysis and in 23–63% undergoing primary coronary
intervention.3 Early on it was interpreted as a positive sign
of reperfusion. However this interpretation has now changed
and most consider RP a manifestation of reperfusion injury.
The RP has been associated with an increase in myocardial in-
farct size, lower left ventricular ejection fraction, higher level
of troponin-T release and NT-pro-brain natriuretic peptide.4
Furthermore a recent work demonstrated adverse cardiac clin-
ical outcomes in patients who developed ST-peak during reper-
fusion compared with those who did not develop a ST-peak.
Rates of cardiac mortality (8% vs. 3%; p= 0.047) and cardiac
events and admission for heart failure (19% vs. 10%,
p= 0.018) were the main ﬁndings.5
As for the pathophysiology the most common opinion is
that RP totally or partially may be due to the rise of heart rate.
This leads to a reduction of the left ventricular diastolic period
and subsequently coronary blood ﬂow.6 Distal embolization
has also been suggested as a cause of RP. However this
hypothesis was not supported in the previously mentioned
investigation. It is possible that RP is an electrophysiological
phenomenon caused by potassium washout during reperfu-
sion, although this needs further study. Some studies have
found an association between transient ST-elevation and pa-
tients who have a large ischemic risk prior to vessel recanaliza-tion. Other investigators argue that RP is certainly caused by
reperfusion injury.4
This is a clinically important question as it may have impli-
cations for the prognosis of patients who experience it. As dis-
cussed there is no uniform agreement as to the
pathophysiologic mechanisms involved in the production of
RP. Because of that lack of understanding, pharmacological
or mechanical therapies have not been developed to modify
it. However, the prevalence of STEMI and reperfusion therapy
is fairly high, making this an important topic to discuss and
understand. Future investigations should focus on the patho-
physiology of this phenomenon. An adequate understanding
of the pathophysiology will help us comprehend the signiﬁ-
cance of RP and design new strategies to achieve better medi-
cal care of these patients.
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